Vyriad Raises $29.5M in Extended Series B Financing
Vyriad is developing oncolytic viruses, which may treat a range of cancers alone or in combination with checkpoint inhibitors.
Source: precisiononcologynews.com
Imanis Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Imanis Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Imanis Life Sciences Today - Breaking & Trending Today
Rochester's Vyriad lands a new $29.5 million round of investment
Stine Seed Farms Inc., led by Iowa billionaire Harry Stine, recently invested $29.5 million in Vyriad Inc. Vyriad, which uses viruses to attack cancer tumors, is based on the Rochester Technology Campus at 3605 U.S. Highway 52 North.
Source: postbulletin.com
Technology firm working on new Rochester lab and offices
Applied Aerosol Technologies has been filing for permits in March and April to create six new offices and a small lab space in Building 103 of the Rochester Technology Campus at 2900 37th St. NW. That’s the former IBM Campus.
Source: postbulletin.com
Oral Vaccine Boosts COVID Immunity
/PRNewswire/ -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced...
Source: prnewswire.com
Researchers in the Med City launch new test to track immunity to omicron variant
ROCHESTER, Minn. - Imanis Life Sciences based in Rochester has created a new test to track immunity to the omicron variant - for at-risk patients.
Source: kimt.com